We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eczema Drugs Prompt FDA Health Advisory on Cancer Risks
Eczema Drugs Prompt FDA Health Advisory on Cancer Risks
March 18, 2005
The FDA has issued a public health warning about the potential cancer risks of two eczema drugs — Novartis Pharmaceutical’s Elidel and Fujisawa Healthcare’s Protopic.